Alvotech Attacks AbbVie Over Adalimumab

Launches US Legal Challenge Over Humira Patent ‘Monopoly’

 
• By David Wallace
  
Danger Minefield Sign
Alvotech has cited the “minefield of IP” around Humira • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products